Peter Radovich - Mar 4, 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
PRESIDENT AND COO
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Mar 4, 2025
Transactions value $
-$676,928
Form type
4
Date filed
3/5/2025, 04:28 PM
Previous filing
Feb 4, 2025
Next filing
Mar 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$623K -13.7K -50.74% $45.57 13.3K Mar 4, 2025 Direct F1
transaction MIRM Common Stock Sale -$53.5K -1.17K -8.8% $45.74 12.1K Mar 4, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average sale price for the transaction reported was $45.571143, and the range of prices were between $45.50 and $45.88. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.